No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
NSB Neuroscientific Biopharmaceuticals Ltd
- 0.037
- -0.002-5.13%
20min DelayNot Open Jan 23 13:43 AET
5.35MMarket Cap18.50P/E (Static)
0.039High0.037Low208.31KVolume0.039Open0.039Pre Close7.71KTurnover0.07852wk High0.20%Turnover Ratio144.60MShares0.03352wk Low0.002EPS TTM3.77MFloat Cap0.540Historical High18.50P/E (Static)101.88MShs Float0.033Historical Low0.002EPS LYR5.13%Amplitude--Dividend TTM1.00P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Neuroscientific Biopharmaceuticals Ltd: 2024 Annual Report & Appendix 4E
Should Weakness in NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Neuroscientific Biopharmaceuticals Secures US FDA Guidance for Glaucoma Medication
NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%
NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
NeuroScientific Biopharmaceuticals CEO to Step Down
Trending Stocks
ASX High Dividend ASX High Dividend